Navigation Links
Opportunities to Invest in Puerto Rico as Global Center for Biotechnology

25% of world's biological manufacturing capacity is in Puerto Rico

MEXICO CITY, Feb. 12 /PRNewswire/ -- A quarter of the world's biotechnology manufacturing capacity is located in Puerto Rico, making it one of the largest concentrations in the world.

Over the past four years, more than $4 billion has been invested in biotechnology in Puerto Rico by such giants as Eli Lilly, Amgen, Abbot, Ortho Biologics, BD Biosciences and Bristol Myers Squibb. The Puerto Rico Conference, Investment for Growth, organized by the Puerto Rico Chamber of Commerce, will feature a panel on The Biotech Island. Panelists will discuss the factors that are making the island so attractive for this type of investment.

The panelists will include Emilio Rivera, Vice-President of Manufacturing Operations of Amgen Puerto Rico, a company that has expanded twice in the past six years and invested $2 billion; Samuel Malone, President of Eli Lilly & Company Puerto Rico; and Edgardo Fabregas, Vice-President of Pharmaceutical Manufacturing at Johnson & Johnson and the person responsible for the corporation's manufacturing operation in Puerto Rico, Asia and Europe. Eli Lilly built the world's largest modular biotechnology facility in Puerto Rico, where it produces Humalog, recombinant human insulin for the treatment of diabetes.

The Puerto Rico Conference, to be held February 19 & 20 at the Hotel Ritz Carlton in San Juan, is aimed at presenting investment opportunities in Puerto Rico. "We organized the conference around the many areas of interest to investors in which Puerto Rico offers unique opportunities," said Francisco Rodriguez-Castro, organizer and Chair of the Conference. "The response so far has been very positive. We are getting a lot of interest from investors in the U.S. and Puerto Rico," he said. "Our mission is to showcase Puerto Rico's business sector and its many possibilities as we strengthen it with this type of event," said Jose Julian Alvarez, Chairman of the Board of the Puerto Rico Chamber of Commerce.

The conference will also focus on a general presentation of Puerto Rico's economy, growing opportunities in the health sector, and banking, financing vehicles available, real estate investment trusts as a new investment opportunity in Puerto Rico, and developments in tourism, retail and communications.

The Puerto Rico Chamber of Commerce is a non-profit organization established in 1913. It is the most inclusive multi-sector organization on the island and it has traditionally been the voice that represents the private sector. Each year, multiple events, such as this one, are organized to promote and facilitate opportunities that will support the socioeconomic development of Puerto Rico. To make reservations and/or obtain more information, log on to; or call 1-787-721-6060 extension 2209 from Monday to Friday during work hours (8:00a.m. to 5:00p.m.).


Nancy Robles

Puerto Rico Chamber of Commerce

(787) 721-6060 ext. 2209

(787) 474-6092 direct.


SOURCE Puerto Rico Chamber of Commerce
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. European blood researchers receive award to pursue research opportunities in US
2. Healthcare Tech and the World: Podcast Examines The Challenges & Opportunities for Change in the Healthcare Industry
3. Perdue AgriBusiness Announces Low Linolenic Soybean Contracting Opportunities with DuPont Business Pioneer Hi-Bred
4. Workplace opportunities and stresses are both increasing
5. Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy
6. Holidays Can Present Drinking Opportunities for Teens
7. Biotech Company Builder Papadopoulos Says Investment in Innovation Needed to Advance Drug Pipeline at Massachusetts Biotechnology Councils Ninth Annual MASS Opportunities Investment Conference
8. Alcohol and cancer -- recent research and prevention opportunities
9. In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer
10. Investor Insight Initiates Analyst Coverage on Crdentia
11. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop ... not only fulfilling the needs of advisers and clients but going above and ... providing top-tier customer service. However, there's always room for improvement, which is why ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... successful and prominent nonprofit healthcare organizations in the country. They have overseen financial ... organizations, and helped advance the healthcare industry as a whole through their advocacy ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term Support) into its ... 11 LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD and Cambridge Memorial ... in the Waterloo region. Using the Ocean Platform, family physicians can now order ... electronic medical record (EMR) without the need for redundant patient entry or an ...
(Date:11/26/2015)... ... ... Jobs in hospital medical laboratories and in the imaging field lead the ... Aureus Medical Group . These fields, as well as travel nursing, ranked ... jobs through the company’s website, , The leading healthcare staffing agency ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
Breaking Medicine Technology: